Normalene Stop Gas® MONTEFARMACO 40 Tablets
- Brand: MONTEFARMACO OTC SpA
- Product Code: 935505255
- EAN: 8058363616392
- Availability: In Stock
- Purchase 3 items for 8.49€ each
- Purchase 4 items for 8.31€ each
- Purchase 5 items for 8.14€ each
Normalene Stop Gas® MONTEFARMACO - Gluten and Lactose Free food supplement
Normalene Stop Gas® is useful for the treatment of aerophagia and intestinal meteorism.
Normalene Stop Gas® is indicated in the treatment of symptoms related to swelling of the stomach (aerophagia) and intestines (meteorism) due to the accumulation of gas .
Relieves the cramps and pains associated with this problem and prevents flatulence and belching.
The action of the product is due to the anti-foaming action of simethicone, combined with the adsorbing action of coal on intestinal gas . The two-layer conformation of the tablet allows about 50% of the ingredients to be released in the gastric environment within 15 minutes of taking, while the complete disintegration of the tablet takes place in the intestinal environment within an hour.
The components are not absorbed in the gastrointestinal tract and do not interfere with the absorption of nutrients.
Gluten -free and lactose -free.
Dosage
It is recommended that adults take 1 or 2 Normalene Stop Gas® tablets at the end of each main meal up to a maximum of 4 tablets per day.
On the other hand, in children aged 14 to 18, take 1 tablet at the end of each main meal up to a maximum of 2 tablets per day.
Warnings
Do not use the product before 14 years of age.
Keep out of reach of children. do not use in the presence of gastric or intestinal lesions.
Do not use in case of intestinal blockage. If you are pregnant or breastfeeding, take Normalene Stop Gas® only if necessary or after consulting your doctor. For periods longer than 30 days of use, it is recommended to stop the treatment for at least 3-5 days.
Normalene Stop Gas is a medical device CE 0426.
Read the warnings and instructions for use carefully.
Ministerial authorization of 12/20/17
Format
Pack of 40 two-layer swallowable tablets with differentiated release.